Loss of P2X7 Receptor Plasma Membrane Expression and Function in Pathogenic B220+ Double-Negative T Lymphocytes of Autoimmune MRL/lpr Mice

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Le Gall, Sylvain M ^a   Legrand, Julie ^b   Benbijja, Mohcine ^a,b   Safya, Hanaa ^a   Benihoud, Karim ^c   Kanellopoulos, Jean M ^d   Bobé, Pierre ^a,b  

^a INSTITUT JACQUES MONOD   (France)

^b INSTITUT ANDRÉ LWOFF   (France)

^c CNRS   (France)

^d INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD39 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; MESSENGER RNA; PURINERGIC P2X7 RECEPTOR; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; B220+ DOUBLE NEGATIVE T LYMPHOCYTE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE FREQUENCY; GENETIC VARIABILITY; HOMEOSTASIS; INTRACELLULAR SIGNALING; LYMPHOCYTE FUNCTION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; BLOTTING, WESTERN; CELL MEMBRANE; CELLS, CULTURED; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED MRL LPR; MICE, MUTANT STRAINS; NAD; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2X7; SIGNAL TRANSDUCTION;

MUS;

EID: 84871350287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052161     Document Type: Article

References (53)

1. Bidère N, Su HC, Lenardo MJ, (2006) Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol 24: 321-352.
2. Mohamood AS, Bargatze D, Xiao Z, Jie C, Yagita H, et al. (2008) Fas-mediated apoptosis regulates the composition of peripheral alphabeta T cell repertoire by constitutively purging out double negative T cells. PLoS One 3: e3465.
3. Thomson CW, Lee BP, Zhang L, (2006) Double-negative regulatory T cells: non-conventional regulators. Immunol Res 35: 163-178.
4. Kinjyo I, Gordon SM, Intlekofer AM, Dowdell K, Mooney EC, et al. (2010) Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin. J Immunol 185: 7151-7155.
5. Renno T, Attinger A, Rimoldi D, Hahne M, Tschopp J, et al. (1998) Expression of B220 on activated T cell blasts precedes apoptosis. Eur J Immunol 28: 540-547.
6. Bleesing JJ, Morrow MR, Uzel G, Fleisher TA, (2001) Human T cell activation induces the expression of a novel CD45 isoform that is analogous to murine B220 and is associated with altered O-glycan synthesis and onset of apoptosis. Cell Immunol 213: 72-81.
7. Hermiston ML, Xu Z, Weiss A, (2003) CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 21: 107-137.
8. Benihoud K, Bonardelle D, Bobé P, Kiger N, (1997) MRL/lpr CD4-CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways. Eur J Immunol 27: 415-420.
9. Bonardelle D, Benihoud K, Kiger N, Bobé P, (2005) B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice. J Leukoc Biol 78: 1052-1059.
10. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, et al. (1995) Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 11: 294-300.
11. Bobé P, Bonardelle D, Reynès M, Godeau F, Mahiou J, et al. (1997) Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease. J Immunol 159: 4197-4204.
12. Bonardelle D, Bobé P, Reynès M, Amouroux J, Tricottet V, et al. (2001) Inflammatory arthropathy in MRL hematopoietic chimeras undergoing Fas mediated graft-versus-host syndrome. J Rheumatol 28: 956-961.
13. Bobé P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK, (2006) Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood 108: 3967-3975.
14. Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, et al. (1984) Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 133: 227-233.
15. Benihoud K, Bonardelle D, Soual-Hoebeke E, Durand-Gasselin I, Emilie D, et al. (2002) Unusual expression of LINE-1 transposable element in the MRL autoimmune lymphoproliferative syndrome-prone strain. Oncogene 21: 5593-5600.
16. Morel L, (2010) Genetics of SLE: evidence from mouse models. Nat Rev Rheumatol 6: 348-357.
17. Elliott JI, McVey JH, Higgins CF, (2005) The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products. Arthritis Res Ther 7: R468-475.
18. Portales-Cervantes L, Nino-Moreno P, Doniz-Padilla L, Baranda-Candido L, Garcia-Hernandez M, et al. (2010) Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. Hum Immunol 71: 818-825.
19. North RA, (2002) Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.
20. Virginio C, MacKenzie A, North RA, Surprenant A, (1999) Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol 519 Pt 2: 335-346.
21. Adriouch S, Dox C, Welge V, Seman M, Koch-Nolte F, et al. (2002) Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J Immunol 169: 4108-4112.
22. Auger R, Motta I, Benihoud K, Ojcius DM, Kanellopoulos JM, (2005) A Role for Mitogen-activated Protein KinaseErk1/2 Activation and Non-selective Pore Formation in P2X7 Receptor-mediated Thymocyte Death. J Biol Chem 280: 28142-28151.
23. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, et al. (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276: 125-132.
24. Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, et al. (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168: 6436-6445.
25. Colomar A, Marty V, Medina C, Combe C, Parnet P, et al. (2003) Maturation and release of interleukin-1beta by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors. J Biol Chem 278: 30732-30740.
26. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, et al. (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176: 3877-3883.
27. Gu B, Bendall LJ, Wiley JS, (1998) Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92: 946-951.
28. Le Gall SM, Bobé P, Reiss K, Horiuchi K, Niu XD, et al. (2009) ADAMs 10 and 17 Represent Differentially Regulated Components of a General Shedding Machinery for Membrane Proteins such as TGF alpha, L-Selectin and TNF alpha. Mol Biol Cell 20: 1785-1794.
29. Lammas DA, Stober C, Harvey CJ, Kendrick N, Panchalingam S, et al. (1997) ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7: 433-444.
30. Coutinho-Silva R, Stahl L, Raymond MN, Jungas T, Verbeke P, et al. (2003) Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity 19: 403-412.
31. Loomis WH, Namiki S, Ostrom RS, Insel PA, Junger WG, (2003) Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation. J Biol Chem 278: 4590-4596.
32. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, et al. (2008) Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 1: ra6.
33. Yip L, Woehrle T, Corriden R, Hirsh M, Chen Y, et al. (2009) Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J 23: 1685-1693.
34. Gonnord P, Delarasse C, Auger R, Benihoud K, Prigent M, et al. (2009) Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts. Faseb J 23: 795-805.
35. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, et al. (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53: 107-118.
36. Seman M, Adriouch S, Scheuplein F, Krebs C, Freese D, et al. (2003) NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19: 571-582.
37. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265.
38. Tsukimoto M, Maehata M, Harada H, Ikari A, Takagi K, et al. (2006) P2X7 Receptor-Dependent Cell Death Is Modulated during Murine T Cell Maturation and Mediated by Dual Signaling Pathways. J Immunol 177: 2842-2850.
39. Mariathasan S, Monack DM, (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7: 31-40.
40. Venturi GM, Tu L, Kadono T, Khan AI, Fujimoto Y, et al. (2003) Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 19: 713-724.
41. Aswad F, Kawamura H, Dennert G, (2005) High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J Immunol 175: 3075-3083.
42. Taylor SR, Alexander DR, Cooper JC, Higgins CF, Elliott JI, (2007) Regulatory T Cells Are Resistant to Apoptosis via TCR but Not P2X7. J Immunol 178: 3474-3482.
43. Hubert S, Rissiek B, Klages K, Huehn J, Sparwasser T, et al. (2010) Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med 207: 2561-2568.
44. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, et al. (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232.
45. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM, (1998) CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160: 1212-1218.
46. Jiang H, Chess L, (2006) Regulation of immune responses by T cells. N Engl J Med 354: 1166-1176.
47. Ford MS, Young KJ, Zhang Z, Ohashi PS, Zhang L, (2002) The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med 196: 261-267.
48. Hamad AR, Mohamood AS, Trujillo CJ, Huang CT, Yuan E, et al. (2003) B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production. J Immunol 171: 2421-2426.
49. Renno T, Hahne M, Tschopp J, MacDonald HR, (1996) Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med 183: 431-437.
50. Elliott JI, Surprenant A, Marelli-Berg FM, Cooper JC, Cassady-Cain RL, et al. (2005) Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 7: 808-816.
51. Holmes N, (2006) CD45: all is not yet crystal clear. Immunology 117: 145-155.
52. Giese T, Davidson WF, (1992) Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. J Immunol 149: 3097-3106.
53. Brooks WP, Lynes MA, (2001) Effects of hemizygous CD45 expression in the autoimmune Fasl(gld/gld) syndrome. Cell Immunol 212: 24-34.